Hypoxia and Tumour Angiogenesis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/978-3-540-33177-3_10
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The hypoxia‐inducible‐factor hydroxylases bring fresh air into hypoxia signalling

  2006cited by this paper
• The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha.

  2006cited by this paper
• Hypoxia signalling in cancer and approaches to enforce tumour regression

  2006cited by this paper
• The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis

  2005cited by this paper
• Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1α (HIF-1α)

  2005cited by this paper
• The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF).

  2005cited by this paper
• Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2α in von Hippel–Lindau renal cell carcinoma

  2005cited by this paper
• Genetic evidence for a tumor suppressor role of HIF-2alpha.

  2005cited by this paper
• OS-9 Interacts with Hypoxia-Inducible Factor 1α and Prolyl Hydroxylases to Promote Oxygen-Dependent Degradation of HIF-1α

  2005cited by this paper
• Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer

  2005cited by this paper
• HIF-1α and p53: the ODD couple?

  2005cited by this paper
• Retinal degeneration and local oxygen metabolism.

  2005cited by this paper
• Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications.

  2005cited by this paper
• Analysis of ARD1 Function in Hypoxia Response Using Retroviral RNA Interference*

  2005cited by this paper
• Decreased Growth of Vhl−/− Fibrosarcomas Is Associated with Elevated Levels of Cyclin Kinase Inhibitors p21 and p27

  2005cited by this paper
• Expression of N-Acetyl Transferase Human and Human Arrest Defective 1 Proteins in Thyroid Neoplasms

  2005cited by this paper
• Mitochondrial tumour suppressors: a genetic and biochemical update

  2005cited by this paper
• Transcriptional regulation of the Vascular Endothelial Growth Factor gene--a concert of activating factors.

  2005cited by this paper
• Transport Activity of MCT1 Expressed in Xenopus Oocytes Is Increased by Interaction with Carbonic Anhydrase*

  2005cited by this paper
• Two transactivation mechanisms cooperate for the bulk of HIF‐1‐responsive gene expression

  2005cited by this paper
• Arrest-defective-1 Protein, an Acetyltransferase, Does Not Alter Stability of Hypoxia-inducible Factor (HIF)-1α and Is Not Induced by Hypoxia or HIF*

  2005cited by this paper
• Something about SUMO inhibits transcription.

  2005cited by this paper
• Differential Gene Up-Regulation by Hypoxia-Inducible Factor-1α and Hypoxia-Inducible Factor-2α in HEK293T Cells

  2005cited by this paper
• Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer.

  2005cited by this paper
• BNip3 and signal-specific programmed death in the heart.

  2005cited by this paper
• Interaction between HIF‐1α (ODD) and hARD1 does not induce acetylation and destabilization of HIF‐1α

  2005cited by this paper
• The hypoxia-inducible factor and tumor progression along the angiogenic pathway.

  2005cited by this paper
• Suppression of Hypoxia-inducible Factor 1α (HIF-1α) Transcriptional Activity by the HIF Prolyl Hydroxylase EGLN1*

  2005cited by this paper
• Activity of Hypoxia-inducible Factor 2α Is Regulated by Association with the NF-κB Essential Modulator*

  2005cited by this paper
• Signalling hypoxia by HIF hydroxylases.

  2005cited by this paper
• Angiogenesis as a therapeutic target

  2005cited by this paper
• Histone Deacetylase 7 Associates with Hypoxia-inducible Factor 1α and Increases Transcriptional Activity*

  2004cited by this paper
• Death by design: apoptosis, necrosis and autophagy.

  2004cited by this paper
• JunD reduces tumor angiogenesis by protecting cells from oxidative stress.

  2004cited by this paper
• CITED4 Inhibits Hypoxia-Activated Transcription in Cancer Cells, and Its Cytoplasmic Location in Breast Cancer Is Associated with Elevated Expression of Tumor Cell Hypoxia-Inducible Factor 1α

  2004cited by this paper
• Autocrine Motility Factor Signaling Enhances Pancreatic Cancer Metastasis

  2004cited by this paper
• Tumor microenvironmental physiology and its implications for radiation oncology.

  2004cited by this paper
• Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway.

  2004cited by this paper
• The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease.

  2004cited by this paper
• Catalytic Properties of the Asparaginyl Hydroxylase (FIH) in the Oxygen Sensing Pathway Are Distinct from Those of Its Prolyl 4-Hydroxylases*

  2004cited by this paper
• Hypoxia and Glucose Metabolism in Malignant Tumors

  2004cited by this paper
• Lactate: mirror and motor of tumor malignancy.

  2004cited by this paper
• The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis

  2004cited by this paper
• Why do cancers have high aerobic glycolysis?

  2004cited by this paper
• Regulation of HIF prolyl hydroxylases by hypoxia‐inducible factors

  2004cited by this paper
• Regulation of angiogenesis by hypoxia: role of the HIF system

  2003cited by this paper
• Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL

  2003cited by this paper
• Targeting HIF-1 for cancer therapy

  2003cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• HLF/HIF‐2α is a key factor in retinopathy of prematurity in association with erythropoietin

  2003cited by this paper
• Structural basis for negative regulation of hypoxia-inducible factor-1α by CITED2

  2003cited by this paper
• The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide.

  2003cited by this paper
• The hypoxic response of tumors is dependent on their microenvironment.

  2003cited by this paper
• Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect

  2003cited by this paper
• HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia

  2003cited by this paper
• Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.

  2003cited by this paper
• Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation

  2003cited by this paper
• Angiogenesis in health and disease

  2003cited by this paper
• The Aryl Hydrocarbon Receptor Nuclear Transporter Is Modulated by the SUMO-1 Conjugation System*

  2002cited by this paper
• Molecular basis of the VHL hereditary cancer syndrome

  2002cited by this paper
• Regulation and Destabilization of HIF-1 by ARD1-Mediated Acetylation

  2002cited by this paper
• Effect of p53 Status on Tumor Response to Antiangiogenic Therapy

  2002cited by this paper
• Articles on similar topics can be found in the following Blood collections

  2002cited by this paper
• Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein.

  2002cited by this paper
• The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma.

  2002cited by this paper
• Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.

  2001cited by this paper
• Tissue oxygen tension and brain sensitivity to hypoxia.

  2001cited by this paper
• pHi, aerobic glycolysis and vascular endothelial growth factor in tumour growth.

  2001cited by this paper
• Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression

  2001cited by this paper
• Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrodes in rodents.

  2001cited by this paper
• FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity.

  2001cited by this paper
• The Expanding Family of Eucaryotic Na+/H+Exchangers*

  2000cited by this paper
• Cancer: looking outside the genome

  2000cited by this paper
• The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

  1999cited by this paper
• Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene.

  1991cited by this paper

• Tumor Oxygenation Status: Facts and Fallacies.

  2017cites this paper
• Hypoxic VDAC1: a potential mitochondrial marker for cancer therapy.

  2014cites this paper
• Hypoxic mitochondria: accomplices in resistance.

  2011cites this paper